
School of Dementia Studies, University of Bradford
This study aims to develop and test a complex intervention to reduce rates of avoidable hospital admissions from nursing homes.
A lot of people go to hospital for conditions that could have been treated in the care home. These avoidable hospital admissions are often for:
Hospitalisation is costly to the NHS and can be distressing to the person, their family and nursing home staff. Nursing home residents are amongst the frailest and most vulnerable members of society. Most have complex health care needs and more than two thirds have dementia. Early identification of changes in residents’ health is essential to ensure active health care in nursing homes.
There are ways to improve health care in care homes:
Nursing home staff want their residents to get timely medical and health care. They don’t like to see their residents going to hospital for conditions that could have been cared for in the home, if detected and reported earlier. We want to develop and test a complex intervention to reduce rates of avoidable hospital admissions from nursing homes.
It is funded by a National Institute for Health Research programme grant. The study started on June 1 2015 and will last 3 years and 3 months. Information will be gathered in London and in West Yorkshire.
There are different levels of Patient and Public Involvement (PPI) in the project. They include:
Each PPI co-applicant, Shirley Nurock and Dr Barbara Woodward-Carlton, chairs one of two Carer Reference Panels for the project, in London and Yorkshire respectively. These panels are composed of people who have or have had family members living in care homes.
The Carer Reference Panels provide an additional level of oversight of the project and provide advice. The next meeting is of the London Panel in June 2018.
We will be consulting about our study with five residents currently living in care homes.
A PPI representative has joined the International Advisory Group for the project, providing a strategic project overview level. The addition of PPI representation has greatly strengthened the work of this group, which is composed primarily of academics and management-level healthcare/care home staff.
Members of the Carer Reference Panels have been invited to attend launch events in the care homes which are participating in our Pilot Trial. These will create an opportunity for Panel members to help with recruitment and to answer any questions about the Trial, particularly from the perspective of family involvement. Panel members have provided invaluable input to the information sheets and briefing notes that we will use at these events.
Carer Reference Panel members have been invited to assist with analysing interview data at a later stage of the Pilot Trial. We have held workshops at meetings in London (above) and Yorkshire where we presented an overview of qualitative data analysis and framework analysis, which is the approach being used in the BHiRCH project.
We are working with the Carer Reference Panels to evaluate the PPI involvement aspect of the BHiRCH study. We will draw on Panel members' prior experiences and perspectives of PPI involvement and initial experiences of getting involved in the BHiRCH study. We will complete two reviews across the life of the study: at the end of the Feasibility study and after the Pilot study. The evaluation will form part of the final report to NIHR (study funder).
In the first year of the BHiRCH project we developed an intervention intended to improve the health of care home residents, and reduce avoidable hospital admissions.
We collected evidence to inform the intervention:
In the second year of the project the team finalised the intervention, which includes assessment and diagnostic tools for the four conditions that people are most likely to be admitted to hospitals when it was avoidable.
The Feasibility Study began in two care homes in October 2016 and ended in February 2017. During the study we:
We received full ethical approval for the Pilot Trial in October 2017 and began recruiting participants in 13 care homes in November 2017. We finished recruitment in January 2018 and are delighted to have recruited 488 individuals across the 13 homes.
We have completed the collection of baseline data and are now collecting on a monthly basis follow-up data in each of the 13 homes.
We have recruited two members of nursing staff - 'Practice Development Champions' - from each of the care homes allocated to receive the intervention, who will train, support and work alongside nurses and care staff to ensure effective introduction and embedding of the intervention. Members of the research team have begun monthly telephone calls to support the champions in the implementation of the intervention.
The International Advisory Group consists of academics and expert professionals in health and social care. We seek their advice at regular intervals throughout the project.
The Group is chaired by Professor Finbarr Martin (Kings College London) and members comprise:
Individual members of the IAG have visited us in person to offer advice and support including:
School of Dementia Studies, University of Bradford
School of Dementia Studies, University of Bradford
University College London
Lancaster University
Queen Margaret University
Patient and Public Involvement
UCL PRIMENT clinical trials unit
Newcastle University Institute for Ageing
University College London
Patient and Public Involvement
Bradford Institute for Health Research
Barchester Health Care
Pro-Vice-Chancellor and Executive Dean of University of Exeter Medical School
University of Surrey
UCL PRIMENT clinical trials unit
UCL PRIMENT clinical trials unit